DHRS3 | Dehydrogenase/reductase (SDR family) member 3 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
DIABLO | Diablo, IAP-binding mitochondrial protein | Disease related genes Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
DLK1 | Delta-like 1 homolog (Drosophila) | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
DLK2 | Delta-like 2 homolog (Drosophila) | Predicted membrane proteins
| | | | | Tissue enhanced |
DMPK | Dystrophia myotonica-protein kinase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
DNAH2 | Dynein, axonemal, heavy chain 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
DNPEP | Aspartyl aminopeptidase | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
DOPEY1 | Dopey family member 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
DPP6 | Dipeptidyl-peptidase 6 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
DSC2 | Desmocollin 2 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DSC3 | Desmocollin 3 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
DSCAM | Down syndrome cell adhesion molecule | Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
DSG1 | Desmoglein 1 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
DSG2 | Desmoglein 2 | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
DSG3 | Desmoglein 3 | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
DYSF | Dysferlin | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
ECE1 | Endothelin converting enzyme 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
EFCAB14 | EF-hand calcium binding domain 14 | Predicted membrane proteins
| | | | | Expressed in all |
EFNB2 | Ephrin-B2 | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EMD | Emerin | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
ENG | Endoglin | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ENPP1 | Ectonucleotide pyrophosphatase/phosphodiesterase 1 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ENTPD1 | Ectonucleoside triphosphate diphosphohydrolase 1 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Mixed |
ENTPD4 | Ectonucleoside triphosphate diphosphohydrolase 4 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
EPCAM | Epithelial cell adhesion molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EPHB3 | EPH receptor B3 | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
EQTN | Equatorin, sperm acrosome associated | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ERGIC1 | Endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ERGIC3 | ERGIC and golgi 3 | Predicted membrane proteins
| | | | | Expressed in all |
ETFDH | Electron-transferring-flavoprotein dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
F11R | F11 receptor | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
FAM159B | Family with sequence similarity 159, member B | Predicted membrane proteins
| | | | | Group enriched |
FAM209B | Family with sequence similarity 209, member B | Predicted membrane proteins
| | | | | Tissue enriched |
FAM69A | Family with sequence similarity 69, member A | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
FAM98B | Family with sequence similarity 98, member B | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
FAM9C | Family with sequence similarity 9, member C | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
FAT2 | FAT atypical cadherin 2 | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
FATE1 | Fetal and adult testis expressed 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
FBXO18 | F-box protein, helicase, 18 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
FCER1A | Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide | FDA approved drug targets Predicted membrane proteins
| | | | | Mixed |
FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | FDA approved drug targets Predicted membrane proteins
| | | | | Expressed in all |
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | CD markers FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
FCGR3A | Fc fragment of IgG, low affinity IIIa, receptor (CD16a) | CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
FCN1 | Ficolin (collagen/fibrinogen domain containing) 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
FCRL1 | Fc receptor-like 1 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FCRLA | Fc receptor-like A | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
FGFR3 | Fibroblast growth factor receptor 3 | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |